2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Slides:

Advertisements

Similar presentations

Breast Cancer Patient Issues in Family Practice: An Interactive Session.

Advertisements

Progress Against Breast Cancer

Baptist Health System General Surgery Residency Program

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.

Breast Cancer in Pregnancy

Breast Cancer Reimbursement Policy in Taiwan Mao-Ting Sheen Director Bureau of National Health Insurance Department of Health, Executive Yuan November.

First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.

Are You Ready to Assess For Distress? Lee Tremback, MA, LCSW, OSW-C Oncology Social Worker Eastern Connecticut Cancer Institute John A. DeQuattro Cancer.

Use Case 7 IHE Profiles & Actors Care Theme: Leveraging Healthcare Registries in Care Delivery Use Case: Optimizing Cancer Care Coordination Leveraging.

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

How are cancer statistics kept up to date?.  Example:  Dx stage II colon cancer  Cancer has metastasized to the liver – 2009  How does the.

Putnam County Hospital CANCER CENTER The Cancer Center is located on the 2 nd floor of Putnam County Hospital. Continuously Accredited by the American.

Breast Cancer Detection, Treatment, and Survival in Medicare and Medicaid Insured Patients Cathy J. Bradley, Ph.D. Professor of Health Administration Co-leader,

Ductal Carcinoma in situ

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

APIII October 23, 2008 Establishing Indicators for Cancer Care: The Role of the Cancer Registry and Other Oncology Data Sources Presented by: Sharon Winters.

Breast Cancer Awareness By: Dominick Phillips. What Is Breast Cancer? If a cell changes into a abnormal, sometimes harmful form, it can divide quickly.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Accountability in Breast and Colorectal Cancer Care Omar M. Rashid MD, JD Complex General Surgical Oncology Fellow.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.

PERFORMANCE IMPROVEMENT. Performance Improvement (PI) Guided by the Mission, Vision, and Goals of the Organization Responsibility of Everyone Data collection.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.

ER and PR Test Estrogen and Progesterone receptor status tests will show whether or not one or both of these hormones fuel the tumor Cancer that is hormone-sensitive.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.

CBACT: Cost Benefit Analysis for Cancer Treatments Adeeti Aggarwal Saratoga High School February 20, 2009.

Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.

San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine.

An Integrated Approach to Breast Cancer Control A flexible approach that can be adapted to national or local circumstances.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Maryland Comprehensive Cancer Control Vinay K. Gupta, MD FACS Maryland State Cancer Liaison Physician June 6, 2014.

© American College of Surgeons 2015—Content cannot be reproduced or repurposed without written permission of the American College of Surgeons. Lima, St.

2013 C ANCER P ROGRAM A NNUAL R EPORT C OLORECTAL CANCER Praneetha Narahari, MD Ellen Malek, CTR Saint Agnes Medical Center Cancer Registry 1303.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2009 – December 31, 2009.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2011 – December 31, 2011 Compiled by Lynn Day, RN BSN CCM CCRP.

CANCER National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.

Joanne Edwards Medical Information Manager ASCO Tech Assessment Update Commercial Implications & Promotional Guidance.

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.

NAACCR June 2010 The System Performance Initiative: A Pan-Canadian Approach 1.

Annals of Oncology 24: 2206–2223, 2013 R3 조영학

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

Cancer Program Annual Outcomes Report 2016

SYMPTOMS | DIAGNOSIS | TREATMENT

THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE

Advanced loco regional Regional breast cancer

Marcelo Calil Instituto Brasileiro de Controle do Câncer

Surgical Cancer Treatment

Cancer Program Annual Outcomes Report 2017

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

Annual Report 2018 Wayne HealthCare Greenville, OH Updated March 2018

Assessment of Breast and Colorectal Cancer Surgery in Manitoba

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

Presentation transcript:

2015 Cancer Program Performance Outcomes

Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on Cancer (CoC) approved cancer program since 1986, providing service to our community, cancer patients and their families as well as physicians, researchers and the State of California Cancer Registry. As part of our CoC accredited status we also participate in the National Cancer Data Base (NCDB) which offers us the opportunity to compare our cancer program’s performance to nationally recognized standards of care. To that end, we continuously monitor all twenty currently available CoC/NCDB quality measures to insure that Saint Agnes Cancer Program consistently provides the highest level of quality patient care. The following Commission on Cancer Accountability and Quality Improvement measures are deemed by the CoC/NCDB to be the most significant to share with our community: Breast measures:  BCSRT: Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer.  MASTRT: Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer with =/> 4 positive regional lymph nodes.  MAC: Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under age 70 with AJCC T1cN0M0, or stage IB – III hormone receptor negative breast cancer.  HT: Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0, or stage IB - III hormone receptor positive breast cancer.  nBx: Image or palpation guided needle biopsy (core of FNA) is performed to establish the diagnosis of breast cancer.

cont. Colon measures  ACT: Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under age of 80 with AJCC Stage III (lymph node positive) colon cancer.  12RLN: At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. Since the inception of NCDB Cancer Program Performance Ratings (CP3R) our designated Comprehensive Community Cancer Program (CCCP) has met and/or exceeded compliance for each of these important quality measures. For your inspection, the following slide display our CoC performance ratings. ***Please note, to insure that measures with low volume can be appropriately gauged, the Commission on Cancer provides a ‘percentage rating’ and indicates whether the facility's percentage rating falls within a 95% confidence interval range to determine compliance.

Saint Agnes Medical Center’s Cancer Program Performance Ratings COMPLIANCE ACHIEVED ALL YEARS All ratings within 95% Confidence Interval Range & Comparable to CoC program type CCCP CoC Measure Rating all years COMPLIANCE MASTRT100%86%100%93% BCSRT100%90%100%97% MAC89%100% 95% HT95%100% 98% nBx91%88%86%88% ACT86%67%100%81% 12RLN88%85%84%86%